Results
2
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
Tibet Rhodiola Pharmaceutical Holding
Market Cap: CN¥12.4b
Tibet Rhodiola Pharmaceutical Holding Co.
600211
CN¥38.35
7D
3.0%
1Y
13.6%
APT Medical
Market Cap: CN¥40.9b
Engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China.
688617
CN¥289.98
7D
-1.7%
1Y
29.3%